LyGenesis

About:

LyGenesis is an organ regeneration company that facilitates organ regeneration and transplant.

Top Investors: Juvenescence, Prime Movers Lab, Longevity Vision Fund

Description:

LyGenesis is an organ regeneration company enabling a patient's own lymph nodes to be used as bioreactors to regrow functioning ectopic organs. Their initial target organ for clinical development is liver regeneration, with a focus on helping patients with end stage liver disease (ESLD).

Total Funding Amount:

$37M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Pittsburgh, Pennsylvania, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)lygenesis.com

Founders:

Michael Hufford

Number of Employees:

1-10

Last Funding Date:

2023-10-24

IPO Status:

Private

Industries: